Gabelli Funds’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,800	Closed	-$563K	–	1360
2021 Q1	$563K	Buy	+13,800	New	+$563K	﹤0.01%	1005
2019 Q3	–	Sell	-6,000	Closed	-$244K	–	1115
2019 Q2	$244K	Sell	6,000 -2,664	-31%	-$108K	﹤0.01%	1059
2019 Q1	$262K	Sell	8,664 -3,336	-28%	-$101K	﹤0.01%	1048
2018 Q4	$403K	Hold	12,000	–	–	﹤0.01%	999
2018 Q3	$506K	Hold	12,000	–	–	﹤0.01%	1008
2018 Q2	$384K	Buy	12,000 +6,000	+100%	+$192K	﹤0.01%	1033
2018 Q1	$298K	Sell	6,000 -1,000	-14%	-$49.7K	﹤0.01%	1053
2017 Q4	$377K	Hold	7,000	–	–	﹤0.01%	1026
2017 Q3	$406K	Hold	7,000	–	–	﹤0.01%	1017
2017 Q2	$345K	Hold	7,000	–	–	﹤0.01%	1047
2017 Q1	$304K	Hold	7,000	–	–	﹤0.01%	1052
2016 Q4	$343K	Hold	7,000	–	–	﹤0.01%	1055
2016 Q3	$335K	Hold	7,000	–	–	﹤0.01%	1067
2016 Q2	$376K	Hold	7,000	–	–	﹤0.01%	1060
2016 Q1	$313K	Hold	7,000	–	–	﹤0.01%	1054
2015 Q4	$267K	Hold	7,000	–	–	﹤0.01%	1064
2015 Q3	$223K	Hold	7,000	–	–	﹤0.01%	1034
2015 Q2	$231K	Hold	7,000	–	–	﹤0.01%	1039
2015 Q1	$288K	Hold	7,000	–	–	﹤0.01%	1018
2014 Q4	$285K	Sell	7,000 -500	-7%	-$20.4K	﹤0.01%	1033
2014 Q3	$275K	Hold	7,500	–	–	﹤0.01%	1041
2014 Q2	$347K	Hold	7,500	–	–	﹤0.01%	1003
2014 Q1	$308K	Sell	7,500 -500	-6%	-$20.5K	﹤0.01%	1002
2013 Q4	$305K	Buy	+8,000	New	+$305K	﹤0.01%	993